Optimizing platelet transfusion thresholds in preterm infants: a systematic review and narrative synthesis of impacts

Dengjun Liu1,2, Qian Gao1,2, Jogender Kumar3

  • 1Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China.

Insights

Restrictive platelet transfusion strategies for preterm infants are safe and may improve long-term outcomes. This supports individualized, evidence-based transfusion practices in neonatal care.

Area of Science:

  • Neonatal Medicine
  • Hematology
  • Pediatric Critical Care

Background:

  • Platelet transfusions are common in preterm infants with thrombocytopenia.
  • Current transfusion strategies vary, lacking definitive evidence for optimal thresholds.
  • Evaluating different platelet transfusion thresholds is crucial for neonatal care.

Purpose of the Study:

  • To assess the impact of restrictive vs. liberal platelet transfusion thresholds on preterm infant outcomes.
  • To inform evidence-based, individualized transfusion strategies for neonates.
  • To evaluate short-term and long-term effects of transfusion thresholds.

Main Methods:

  • Systematic literature search of PubMed, Embase, and Cochrane Library up to December 2024.
  • Inclusion of comparative studies on restrictive vs. liberal transfusion strategies in thrombocytopenic neonates.
  • Analysis of data from three randomized controlled trials and two cohort studies.

Main Results:

  • Restrictive transfusion strategies did not elevate short-term adverse events.
  • A potential reduction in mortality was observed with restrictive strategies.
  • Severe neurodevelopmental impairment at 2 years corrected age may be reduced.

Conclusions:

  • Restrictive platelet transfusion thresholds (20-25×10^9/L) appear safe for preterm infants.
  • These thresholds may enhance long-term prognosis, including reduced neurodevelopmental impairment.
  • Findings advocate for individualized, evidence-based platelet transfusion practices in neonatal intensive care.
Abstract